Relative Immunogenicity of Streptomycin-Sensitive and -Resistant Strains of BCG

AUTOR(ES)

Collins, F. M.

RESUMO

Normal, specific pathogen-free mice were vaccinated intravenously with increasing amounts of a streptomycin-resistant variety of BCG Tice (BCG SMR). The behavior of BCG SMR in the lungs, liver, and spleen was followed quantitatively for up to 50 days. One or two intravenous doses of 106 viable organisms were steadily eliminated from the tissues without producing detectable tuberculin sensitivity or raising resistance to a subsequent challenge with Mycobacterium tuberculosis strain Erdman. But mice receiving six weekly injections of 106 viable BCG SMR or a single injection of 106 BCG SMR by the intravenous route did develop effective levels of antituberculous resistance. Heat inactivation of the BCG SMR inoculum removed the organism's protective activity which could, however, be restored by incorporation of the organisms into Freund adjuvant. The ability of living BCG SMR to induce an effective antituberculous resistance when introduced into the tissues in an appropriate manner is discussed in terms of the mechanism of antituberculous immunity.

Documentos Relacionados

• STUDIES ON THE RIBOSOMES OF STREPTOMYCIN-SENSITIVE AND RESISTANT STRAINS OF ESCHERICHIA COLI*
• The Behaviour of Mixtures of Streptomycin-sensitive and -resistant Tubercle Bacilli in Liquid Medium Sensitivity Tests
• Accumulation of 14C-Streptomycin by Streptomycin-sensitive and Streptomycin-resistant Group H Streptococci
• GROWTH COMPARISONS OF STREPTOMYCIN-SENSITIVE AND STREPTOMYCIN-RESISTANT MICROCOCCUS PYOGENES VAR. AUREUS1
• THE REPLACEMENT OF STREPTOMYCIN-RESISTANT COLIFORM BACTERIA IN THE STOOLS BY STREPTOMYCIN-SENSITIVE VARIANTS DURING AND FOLLOWING THE CESSATION OF STREPTOMYCIN THERAPY 12